MD Medical Group

MD Medical Group is a leading private healthcare provider in Russia focused historically on women’s health, obstetrics, gynecology, fertility treatment, and pediatrics, and it has expanded into broader multidisciplinary care including oncology, cardiology, surgery, trauma, rehabilitation, diagnostics, and laboratory services. The company operates the "Mother & Child" and MD Group network of hospitals and outpatient clinics across multiple Russian regions. Unlike a biotech or pharma developer, MD Medical Group is primarily a healthcare delivery company rather than a drug R&D business, so it does not disclose a therapeutic pipeline in the conventional biotech sense. The company is publicly traded on the Moscow Exchange under the ticker MDMG following its 2024 redomiciliation to Russia. Its business model centers on private-pay and insured medical services, fertility and IVF, hospital-based care, outpatient visits, and related diagnostics and pharmacy services.